Jon E. Peterson

Immunology and Microbiology · Life Sciences

13h-index931citations27works20.02yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Biosimilars and Bioanalytical Methods(5), Hepatitis C virus research(4), Hepatitis B Virus Studies(4), Angiogenesis and VEGF in Cancer(4), PARP inhibition in cancer therapy(4)

Publications26 total

The Clinical Development of Taldefgrobep Alfa: An Anti-Myostatin Adnectin for the Treatment of Duchenne Muscular Dystrophy
Neurology and Therapy·2024· 20 citedOpen Access
Calibrator Material Selection: A Key Criteria During Biomarker Assay Method Development
Bioanalysis·2021· 3 cited
Integration of Acoustic Liquid Handling into Quantitative Analysis of Biological Matrix Samples
SLAS TECHNOLOGY·2020· 5 citedOpen Access
Considerations for Soluble Protein Biomarker Blood Sample Matrix Selection
The AAPS Journal·2020· 7 cited
Surface Plasmon Resonance as a Tool for Ligand-Binding Assay Reagent Characterization in Bioanalysis of Biotherapeutics
Bioanalysis·2018· 17 cited
Highly Selective and Sensitive Measurement of Active forms of FGF21 Using Novel Immunocapture Enrichment with LC–MS/MS
Bioanalysis·2017· 9 cited
Strategy for the Quantitation of a Protein Conjugate via Hybrid Immunocapture-Liquid Chromatography with Sequential HRMS and SRM-Based LC-MS/MS Analyses
Analytical Chemistry·2017· 17 cited
Development and Validation of Electrochemiluminescence Assays to Measure Free and Total sSLAMF7 in Human Serum in the Absence and Presence of Elotuzumab
The AAPS Journal·2016· 8 cited
Development and Fit-for-Purpose Validation of a Soluble Human Programmed Death-1 Protein Assay
The AAPS Journal·2015· 12 citedOpen Access
VEGF, PF4 and PDGF are elevated in platelets of colorectal cancer patients
Angiogenesis·2012· 234 cited
Normal ranges of angiogenesis regulatory proteins in human platelets
American Journal of Hematology·2010· 159 citedOpen Access
Platelet-associated PF-4 as a biomarker of early tumor growth
Blood·2007· 145 citedOpen Access
Can Angiogenesis Regulatory Proteins Guide Ultra-early Detection and Therapy of Recurrent Human Cancer?
Clinical Cancer Research·2007
Impact of HCV 3.0 EIA relative to HCV 2.0 EIA on blood‐donor screening
Transfusion·2003· 43 cited
Detection of HCV core antigen in HCV RNA positive, anti‐HCV negative blood donations from Polish blood donors
Transfusion·2001· 19 cited
Lack of association between acquisition of TT virus and risk behavior for HIV and HCV infection in Vietnam
International Journal of Infectious Diseases·1999· 6 citedOpen Access
Gradual loss of IgG antibodies against GB virus C/hepatitis G virus in a patient with AIDS.
PubMed·1998· 1 cited
Prevalence of Hepatitis G Virus Among Intravenous Drug Abusers in Los Angeles
Clinical Infectious Diseases·1997· 11 citedOpen Access
Effect of an arginine-specific ADP-ribosyltransferase inhibitor on differentiation of embryonic chick skeletal muscle cells in culture
Experimental Cell Research·1992· 37 cited
Determination of the kinetic mechanism of arginine-specific ADP-ribosyltransferases using a high performance liquid chromatographic assay.
Journal of Biological Chemistry·1991· 20 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Joseph E. Italiano(4), Giannoula Klement(4), Judah Folkman(4), Alexander Kozhich(4), D J Graves(3), Stephen R. Lee(3), Xiling Yuan(3), Lora Hamuro(3), Rasa Santockyte(3), Steven P. Piccoli(3), David Zurakowski(2), Lea Michel(2), Susan L. Connors(2), George N. Naumov(2), Nava Almog(2), J S Larew(2), Hugh J. McMillan(2), Monique M. Ryan(2), Mathew T. Pletcher(2), Frank Zambito(2)